Diagnostics · Nov 17, 2026
More than a Second Pair of Eyes: Artificial Intelligence Across the Breast Imaging Pathway
By Pesapane F, Chiarpenello V, Arnone F et al.
Artificial intelligence (AI) is moving from stand-alone accuracy studies to prospective deployment across breast screening, risk prediction, multimodal diagnosis, treatment response, and workflow support. The goal of this narrative review is to determine which AI applications have demonstrated clinical benefit, which remain technically promising, and what safeguards are required for implementation. We synthesize randomized trials, prospective cohorts, real-world implementations, external validations, systematic reviews, and guidance identified in PubMed/MEDLINE and Scopus through 30 June 2026. In screening, AI-supported mammography can increase cancer detection and reduce reading workload, but effects depend on whether AI is used as concurrent support, an independent reader, triage, or partial autonomy; autonomous workflows may shift work and cost downstream through additional recalls. MASAI met its prespecified noninferiority criterion for interval cancer, but this should not be interpreted as proof of equivalence or mortality benefit. Image-based risk models often discriminate better than density or conventional clinical models, although prospective benefit from AI-guided allocation to supplemental imaging has not yet been demonstrated. Evidence for contrast-enhanced mammography (CEM), MRI, ultrasound, radiomics, and multimodal models is less mature and limited by external validation, domain shift, missing data, operator dependence, and uncertain incremental value beyond clinicopathological factors. Ungrounded large language models and opaque foundation models are not suitable for autonomous clinical advice. Current evidence therefore supports controlled, task-specific integration rather than radiologist replacement; real clinical benefit depends on governance of the whole AI-enabled pathway, including local validation, human factors, downstream resource use, statistical stopping rules, and fallback procedures.